-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
April 02, 2015 - are benefits of very long chain polyunsaturated fatty
acids (EPA and DHA) for reducing the risk of adverse … Adverse events:
• What adverse effects are related to n-3 FA intake or biomarker concentrations
( … • What adverse events are reported specifically among people with CVD or
diabetes (in studies of CVD … • Exclude n-3 FA dose ≥6 g/day (except for adverse events)
Source: www.effectivehealthcare.ahrq.gov … density lipoprotein cholesterol [LDL-c], total/HDL-c ratio, LDL-c/HDL-c
ratio, triglycerides)
• Adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - The most common adverse reactions occurring in patients treated
with pirfenidone compared with placebo … patients may require
a dose reduction to 100 mg, twice daily, or treatment interruption to manage adverse … The most common
adverse reactions occurring in patients treated with nintedanib compared with placebo … impact potential, more data demonstrating
reductions in transplantation-associated complications, adverse … However, two clinical experts
stated that adverse events could reduce patient acceptance.41,47 One
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
February 07, 2025 - events (grade 3, 4, 5)
• Direct mild treatment adverse events (grade
1, 2)
• Indirect adverse … for pain
management)
N/A
Timing All KQs:
Any follow-up duration for grade 3-5 or indirect
adverse … events and quality of life; minimum of 1 year
for grade 1-2 adverse events; minimum of 3 months
for … For direct treatment adverse events (AEs) and indirect treatment-related AEs, we will prioritize
using … We will summarize time-to-event outcomes (overall survival and progression-free survival) with
hazard
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
January 01, 2014 - goals for patients with
UA/NSTEMI involve the elimination of ischemic
pain and the prevention of adverse … Finally, all three KQs consider
safety risks, including adverse drug reactions, bleeding,
and stent … The safety outcomes were framed to
help identify adverse events, including adverse drug
reactions and … • While the use of GPIs reduces the rates of the adverse
events mentioned above, the tradeoff is … rates of cardiovascular mortality usually
dominate the event rates for total mortality.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - effects,
dropouts, dropouts due to adverse effects, treatment
discontinuation due to adverse effects … effects, and dropouts due to adverse effects. … effects, and patients reporting at least one adverse effect. … However, adverse
effects of pharmacologic therapies and long-term treatment
withdrawals due to adverse … Both short- and long-term
adverse effects and treatment withdrawals due to adverse
effects or lack
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-hospitalized-adults-evidence-summary_0.pdf
October 01, 2021 - length of stay, activities of daily
living, discharge disposition, hospital acquired conditions, or adverse … These studies had several
shortcomings, including high risk of bias and poor reporting of adverse events
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-249-malnutrition-hospitalized-adults-evidence-summary.pdf
October 01, 2021 - length of stay, activities of daily
living, discharge disposition, hospital acquired conditions, or adverse … These studies had several
shortcomings, including high risk of bias and poor reporting of adverse events
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
July 06, 2015 - International geographic variation in event rates in trials of
heart failure with preserved and reduced … Since the only trial evaluating an ARB did not report
adverse event results, our results cannot be applied … event; FU=follow-up; SR=systematic review; MA=meta-analysis; IPD=individual patient data; CV=cardiovascular … and 30 (20%) on valsartan had one or more serious adverse
event. … Since the only trial
evaluating an ARB did not report
adverse event results, our results
cannot be
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - Monitoring also includes assessment of any adverse effects of treatment. … In question 1d, we will assess whether the literature suggests
whether these adverse effects differ … Questions 2 and 3 will review
effectiveness as well as adverse outcomes.
III. … event reporting) … event outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - We did not move major adverse cardiovascular events (MACE)
from final health outcomes to harms, because … , differential loss to followup, overall loss to followup, use of
intention to treat, blinding of event … confounding, baseline differences, method to ascertain
exposure, methods to ascertain outcomes, blinding of event … change scores will
be calculated using the method proposed by Follman and colleagues.
22
In the event … The pooled effect estimate will be
used with the range of control event rates from the trials included
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
July 24, 2013 - What are the adverse effects or harms associated with imaging-based surveillance
strategies? … What are the adverse effects or harms associated with using imaging techniques related to
testing or … o Key Questions 1d, 2d, and 3d (Adverse Events or Harms)
Adverse effects or harms associated with … Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will … anxiety, adverse events
secondary to venipuncture, contrast allergy, exposure to
radiation)
Adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - What are the significant agent-specific harms/adverse effects of
nonhormone therapies? … Question 4
Does effectiveness and adverse effects vary among subgroups of patients defined by … Also considered are consequential adverse effects among women
using hormone therapies; these adverse … Finally,
adverse events accompanying the use of nonhormone agents are also depicted. … ((((“adverse effects” [Subheading]) OR “complications” [Subheading]) OR ( “poisoning”
[Subheading] OR
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - No serious adverse events were reported. … event reported in the 3-year, phase III clinical trial for the
fluocinolone acetonide implant was … fluocinolone
acetonide compared with those adverse-event rates in the sham group. 90
Clinical Pathway … Over 2 years, the
most frequent ocular serious AE [adverse event] (SAE) and AE were cataract
(2.1% … Exenatide study of
cardiovascular event lowering trial (EXSCEL): a
trial to evaluate cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
January 01, 2014 - We have added the missing TRITON-TIMI event
rate. … bias,
where sicker patients with more comorbidites are treated with a
PPI and therefore have more adverse … We have added the missing TRITON-TIMI event
rate. … Two
adverse drug reactions values are presented and the type of
adverse reaction is not shown. … drug
reactions Dyspnea at 12 months Ticagrelor 1274/9235
Clopidogrel 717/9186 Adverse drug reactions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
June 15, 2010 - metabolic disturbance, Sleep, Cardiovascular system problems, Geriatric toxicity
problems, Other common adverse … Note that
in Embase alone there are over 7,000 articles that “focus” on adverse events relating to … collecting and reporting harms
using the McHarm Tool; this tool has been specifically designed for adverse … suggest that industry sponsorship may lead to negative trials not being published15, that
reporting of adverse … Is there evidence for biased reporting of published adverse
effects data in pharmaceutical industry-funded
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
July 01, 2012 - continuous positive
airway pressure (CPAP), associated with less morbidity,
lower mortality, fewer adverse … In general, the figure shows that this CER compares
morbidity, mortality, adverse events, and health … Adverse events considered are
aspiration, secondary infections (including pneumonia
and sinusitis), … The safety outcomes were framed to help identify
adverse events, including hospital-acquired pneumonia … We included common
outcomes of interest such as mortality and adverse events,
but also examined more
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - Prespecified
interim analysis of major adverse cardiovascular events is anticipated by mid-2015 and … After 6 months of treatment, the event rates decreased
from 28 to 16 in the pump-only group vs 175 … No
serious adverse events were reported. … Adverse event profiles
were similar across groups. … Rate
of serious adverse effects in a series of
bevacizumab and ranibizumab injections.
-
effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
March 21, 2016 - event
reporting: 35.5% of patients required a device
revision, replacement or explant. … Specifically, the majority of adverse event are resolved
spontaneously, with re-programming of the device … possible that 25% of the
'community dwelling population' has FI - it might be that 25%
had an ABL event … If you are really trying to discuss
ostomy as a surgical adverse event, add ileostomy to
colostomy, … Hull 2013 has
been added to Appendix table F9 (KQ 2) of
adverse effects.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
November 01, 2009 - Seventy-five percent of studies (188) reported the adverse events. … crude rates at specific followup
durations (e.g., at 5 years or at the end of followup) or as time-to-event … The number of patients who
experienced at least one severe or serious adverse event was not routinely … event or harm that was not already listed in the studies included in
the literature scan. … Adverse events, harms, and safety issues reported
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
January 01, 2012 - Research indicates that individuals can reduce their risk of obesity-related
adverse health conditions … preventive practices for females of reproductive potential and immediate drug
discontinuation in event … While several experts mentioned the uncertainty of long-
term adverse events as a potential barrier … Adverse events were reported in 100% of patients in this study. … discontinuation rate, which they believe to be significant adverse
factors.